Prasad V. Saraph

Learn More
The Biotech industry is still an emerging application area for simulation techniques. This paper describes the hierarchical discrete event simulation efforts at Bayer Corporation's Berkeley facility that manufactures second-generation recombinant DNA technology based drug, Kogenate-FS®. The facility consists of multiple manufacturing areas housing(More)
Use of simulation for capacity analysis is an upcoming field in Biotech industry. This paper discusses an application of discrete event simulation in the multi-product and multi-resource Filling Freeze Drying facility of Bayer Corporation's Berkeley site. The SIGMA® simulation model was used to estimate the current and future throughput capacity by(More)
This paper discusses an application of discrete event simulation in analyzing packaging capacity at Bayer Corporation's Berkeley, California facility. A discrete event simulation model was used to estimate output under differing employee staffing and scheduling policies, taking into consideration product and equipment requirements. This model was also used(More)
Simulation is a relatively new tool for business process analysis in the Biotech industry. This paper discusses an application of discrete event simulation in analyzing the capacity needs of a shared resource in the manufacturing facility at Bayer Corporation's Berkeley site. The SIGMA® simulation model was used to analyze the workload patterns, run(More)
  • 1